• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease.

作者信息

Błaszczyk Janusz W

机构信息

Neurophysiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Human Behavior, Jerzy Kukuczka Academy of Physical Education in Katowice, Katowice, Poland.

出版信息

Front Aging Neurosci. 2018 Oct 5;10:301. doi: 10.3389/fnagi.2018.00301. eCollection 2018.

DOI:10.3389/fnagi.2018.00301
PMID:30344487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6182092/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/987f/6182092/781cb3419019/fnagi-10-00301-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/987f/6182092/781cb3419019/fnagi-10-00301-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/987f/6182092/781cb3419019/fnagi-10-00301-g0001.jpg

相似文献

1
The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease.能量代谢与神经保护策略在帕金森病中的新作用
Front Aging Neurosci. 2018 Oct 5;10:301. doi: 10.3389/fnagi.2018.00301. eCollection 2018.
2
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.靶向线粒体丙酮酸载体的能量代谢作为减轻神经退行性变的新方法。
Mol Neurodegener. 2018 May 24;13(1):28. doi: 10.1186/s13024-018-0260-x.
3
Treatment of Parkinson's disease : what's on the horizon?帕金森病的治疗：未来有何进展？
CNS Drugs. 2005;19(9):723-43. doi: 10.2165/00023210-200519090-00001.
4
Progresses in both basic research and clinical trials of NAD+ in Parkinson's disease.在帕金森病中 NAD+ 的基础研究和临床试验都取得了进展。
Mech Ageing Dev. 2021 Jul;197:111499. doi: 10.1016/j.mad.2021.111499. Epub 2021 May 11.
5
Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection.胃饥饿素在帕金森病中具有神经保护作用：代谢神经保护的分子机制。
Ther Adv Endocrinol Metab. 2013 Feb;4(1):25-36. doi: 10.1177/2042018813479645.
6
Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk.二甲双胍在帕金森病中的新兴神经保护作用：一种分子串扰。
Pharmacol Res. 2020 Feb;152:104593. doi: 10.1016/j.phrs.2019.104593. Epub 2019 Dec 13.
7
MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies.以MPTP和6-羟基多巴胺诱导的神经退行性变作为帕金森病模型：神经保护策略
J Neurol. 2000 Apr;247 Suppl 2:II95-102. doi: 10.1007/pl00022909.
8
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.帕金森病神经保护治疗的发展线索及评估治疗效果的脑成像方法。
Eur J Pharmacol. 1999 Jun 30;375(1-3):75-86. doi: 10.1016/s0014-2999(99)00260-5.
9
Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson's disease.胰岛素样生长因子-2在6-羟基多巴胺诱导的帕金森病细胞和小鼠模型中的神经保护作用。
Neural Regen Res. 2023 May;18(5):1099-1106. doi: 10.4103/1673-5374.355815.
10
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.四环素在神经退行性疾病中的再利用：聚焦帕金森病。
J Neural Transm (Vienna). 2018 Oct;125(10):1403-1415. doi: 10.1007/s00702-018-1913-1. Epub 2018 Aug 14.

引用本文的文献

1
Immune cell metabolic dysfunction in Parkinson's disease.帕金森病中的免疫细胞代谢功能障碍
Mol Neurodegener. 2025 Mar 24;20(1):36. doi: 10.1186/s13024-025-00827-y.
2
A non-redundant role of EAAT3 for ATP synthesis mediated by GDH in dopaminergic neuronal cells: a new avenue for glutamate metabolism and protection in Parkinson's disease.EAAT3在多巴胺能神经元细胞中对GDH介导的ATP合成的非冗余作用：帕金森病中谷氨酸代谢和保护的新途径。
FEBS J. 2025 Jun;292(12):3224-3241. doi: 10.1111/febs.70053. Epub 2025 Mar 5.
3
Adenylate kinase 5 deficiency impairs epididymal white adipose tissue homeostasis and decreases fat mass.

本文引用的文献

1
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.靶向线粒体丙酮酸载体的能量代谢作为减轻神经退行性变的新方法。
Mol Neurodegener. 2018 May 24;13(1):28. doi: 10.1186/s13024-018-0260-x.
2
NAD biosynthesis, aging, and disease.烟酰胺腺嘌呤二核苷酸生物合成、衰老与疾病。
F1000Res. 2018 Feb 1;7:132. doi: 10.12688/f1000research.12120.1. eCollection 2018.
3
NAD Intermediates: The Biology and Therapeutic Potential of NMN and NR.NAD 中间体：NMN 和 NR 的生物学和治疗潜力。
腺苷酸激酶5缺乏会损害附睾白色脂肪组织的稳态并减少脂肪量。
J Vet Sci. 2025 Jan;26(1):e5. doi: 10.4142/jvs.24269. Epub 2024 Dec 18.
4
Identification of metabolites reproducibly associated with Parkinson's Disease via meta-analysis and computational modelling.通过荟萃分析和计算建模鉴定与帕金森病可重复相关的代谢物。
NPJ Parkinsons Dis. 2024 Jun 29;10(1):126. doi: 10.1038/s41531-024-00732-z.
5
Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson's disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration.帕金森病的Engrailed-1半合子小鼠模型中的黑质转录组图谱揭示了与多巴胺能神经变性延迟相关的氧化磷酸化相关基因的上调。
Front Aging Neurosci. 2024 Feb 5;16:1337365. doi: 10.3389/fnagi.2024.1337365. eCollection 2024.
6
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.遗传与生化研究进展：揭示帕金森病神经退行性变的病因发病机制。
Biomolecules. 2024 Jan 5;14(1):73. doi: 10.3390/biom14010073.
7
Impaired neuron differentiation in GBA-associated Parkinson's disease is linked to cell cycle defects in organoids.GBA相关帕金森病中神经元分化受损与类器官中的细胞周期缺陷有关。
NPJ Parkinsons Dis. 2023 Dec 18;9(1):166. doi: 10.1038/s41531-023-00616-8.
8
Metabolites of Life: Phosphate.生命的代谢产物：磷酸盐。
Metabolites. 2023 Jul 19;13(7):860. doi: 10.3390/metabo13070860.
9
Protective Effect of Ergothioneine against 7-Ketocholesterol-Induced Mitochondrial Damage in hCMEC/D3 Human Brain Endothelial Cells.麦硫因对 7-酮胆固醇诱导的 hCMEC/D3 人脑微血管内皮细胞线粒体损伤的保护作用。
Int J Mol Sci. 2023 Mar 13;24(6):5498. doi: 10.3390/ijms24065498.
10
Druggable transcriptomic pathways revealed in Parkinson's patient-derived midbrain neurons.帕金森病患者来源的中脑神经元中揭示的可药物作用的转录组学通路。
NPJ Parkinsons Dis. 2022 Oct 18;8(1):134. doi: 10.1038/s41531-022-00400-0.
Cell Metab. 2018 Mar 6;27(3):513-528. doi: 10.1016/j.cmet.2017.11.002. Epub 2017 Dec 14.
4
Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson's disease.衰老大脑中的黑质纹状体相互作用：帕金森病的新治疗靶点。
Acta Neurobiol Exp (Wars). 2017;77(1):106-112. doi: 10.21307/ane-2017-041.
5
The MPTP Story.MPTP 的故事。
J Parkinsons Dis. 2017;7(s1):S11-S19. doi: 10.3233/JPD-179006.
6
Corrigendum to "Parkinson's disease: Autoimmunity and neuroinflammation" [Autoimmun Rev 15 (10) (2016) 1005-1011].《帕金森病：自身免疫与神经炎症》[《自身免疫性疾病评论》15(10)(2016)1005 - 1011]的勘误
Autoimmun Rev. 2016 Dec;15(12):1210. doi: 10.1016/j.autrev.2016.09.027. Epub 2016 Oct 7.
7
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.烟酰胺核糖在小鼠和人类中具有独特的口服生物利用度。
Nat Commun. 2016 Oct 10;7:12948. doi: 10.1038/ncomms12948.
8
Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis.帕金森病与神经退行性变：GABA衰竭假说
Front Neurosci. 2016 Jun 9;10:269. doi: 10.3389/fnins.2016.00269. eCollection 2016.
9
Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk.烟酰胺核糖是牛奶中的一种主要NAD⁺前体维生素。
J Nutr. 2016 May;146(5):957-63. doi: 10.3945/jn.116.230078. Epub 2016 Apr 6.
10
Physiological and pathophysiological roles of NAMPT and NAD metabolism.NAMPT 和 NAD 代谢的生理和病理生理作用。
Nat Rev Endocrinol. 2015 Sep;11(9):535-46. doi: 10.1038/nrendo.2015.117. Epub 2015 Jul 28.